These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 16305286)
1. Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics. Drusano GL Pharmacotherapy; 2005 Dec; 25(12 Pt 2):150S-158S. PubMed ID: 16305286 [TBL] [Abstract][Full Text] [Related]
2. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. Drusano GL; Craig WA J Chemother; 1997 May; 9 Suppl 3():38-44. PubMed ID: 9248979 [TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study. Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549 [TBL] [Abstract][Full Text] [Related]
4. Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective. Zeitlinger M; Wagner CC; Heinisch B Clin Pharmacokinet; 2009; 48(1):23-38. PubMed ID: 19071882 [TBL] [Abstract][Full Text] [Related]
5. Future in vitro and animal studies: development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics. Nightingale CH Pharmacotherapy; 2005 Dec; 25(12 Pt 2):146S-149S. PubMed ID: 16305285 [TBL] [Abstract][Full Text] [Related]
10. [Monitoring of antibiotic treatment of patient with a severe bacterial infection]. Aubert G; Carricajo A Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959 [TBL] [Abstract][Full Text] [Related]
11. Clinical implications of macrolide resistance in community-acquired respiratory tract infections. Hoban DJ; Zhanel GG Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414 [TBL] [Abstract][Full Text] [Related]
12. Impact of pharmacodynamics on dosing of macrolides, azalides, and ketolides. Maglio D; Nicolau DP; Nightingale CH Infect Dis Clin North Am; 2003 Sep; 17(3):563-77, vi. PubMed ID: 14711077 [TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: a Monte Carlo simulation analysis. Noreddin AM; Reese AA; Ostroski M; Hoban DJ; Zhanel GG Clin Ther; 2007 Dec; 29(12):2685-9. PubMed ID: 18201584 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection. Xiao XM; Xiao YH Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632 [TBL] [Abstract][Full Text] [Related]
15. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects. Conte JE; Golden JA; McIver M; Zurlinden E Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169 [TBL] [Abstract][Full Text] [Related]
16. Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogens. Schaper KJ; Schubert S; Dalhoff A Infection; 2005 Dec; 33 Suppl 2():3-14. PubMed ID: 16518706 [TBL] [Abstract][Full Text] [Related]
18. The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Jain R; Danziger LH Curr Pharm Des; 2004; 10(25):3045-53. PubMed ID: 15544496 [TBL] [Abstract][Full Text] [Related]
19. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections. Appelbaum PC Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544 [TBL] [Abstract][Full Text] [Related]
20. Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials. Nuermberger E Pharmacotherapy; 2005 Dec; 25(12 Pt 2):134S-139S. PubMed ID: 16305283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]